Subscribe
shutterstock_2183917051_t-schneider
T. Schneider / Shutterstock.com
12 October 2023FeaturesAmericasMary Prendergast, Mark Whitaker and Nicole Ang

Is the ITC the right venue for trade secrets theft?

Imagine this scenario: you suspect that an employee has walked out with your trade secrets or that a development partner has decided to make their own product using your IP. It seems increasingly likely you’ll need to file a lawsuit to get your trade secrets back or prevent your competitor from using them.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Could Apple face an ITC import ban of its watches?
17 January 2023   With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.
Biotechnology
ITC to investigate Alvotech’s Humira biosimilar
27 January 2022   The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Could Apple face an ITC import ban of its watches?
17 January 2023   With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.
Biotechnology
ITC to investigate Alvotech’s Humira biosimilar
27 January 2022   The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.

More on this story

Americas
Could Apple face an ITC import ban of its watches?
17 January 2023   With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.
Biotechnology
ITC to investigate Alvotech’s Humira biosimilar
27 January 2022   The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Apple wins just $250 in Masimo smartwatch clash
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar